Il-15 an immunoregulatory and anti-cancer cytokine. Recent advances

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 4, 2006, Pages 529-536

  Shanmugham, L N ^a   Petrarca, C ^c   Frydas, S ^d   Donelan, J ^b   Castellani, M L ^e   Boucher, W ^b   Madhappan, B ^b   Tete, S ^c   Falasca, K ^c   Conti, P ^c   Vecchiet, Jacopo ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHIETI   (Italy)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e University of Chieti Pescara ^*

Author keywords

Cancer; Cytokines; IL 15; Immunity; Interleukins

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; TUMOR ANTIGEN;

ANTINEOPLASTIC ACTIVITY; B LYMPHOCYTE; CANCER; CD8+ T LYMPHOCYTE; CELL STIMULATION; DENDRITIC CELL; IMMUNITY; IMMUNOREGULATION; INFLAMMATION; LYMPHATIC LEUKEMIA; MACROPHAGE; MAST CELL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CYTOKINES; DISEASE PROGRESSION; HEMATOLOGIC NEOPLASMS; HUMANS; INTERLEUKIN-15; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MAST CELLS; T-LYMPHOCYTES;

EID: 33846522813     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Cruse J.M. and Lewis R.E. Cytokines and chemokines. In Atlas of Immunology, J.M. Cruise and R.E. Lewis, ed. CRC Press LLC Boca Raton , p.285, 2004.
2. Musso T., Cappello P., Stornello S., Ravarino D., Caorsi C., Otero K., Novelli F., Badolato R., Giovarelli M. IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytes. Int. J. Immunopathol. Pharmacol. 18(2):339-49, 2005.
3. Midulla F., Tromba V., Lo Russo L., Mileto F., Sabatino G., Sgarrella M., Panuska J.R., Manganozzi L., Korn D., Moretti C. Cytokines in the nasal washes of children with respiratory syncytial virus bronchiolitis. Int. J. Immunopathol. Pharmacol. 19(1):231-5, 2006.
4. Passam F.H., Alexandrakis M.G., Moschandrea J., Sfiridaki A., Roussou P.A., Siafakas N.M. Angiogenic molecules in Hodgkin inverted exclamation mark|s disease: results from sequential serum analysis. Int. J. Immunopathol. Pharmacol. 19(1):161-70, 2006.
5. Capoluongo E., Vento G., Ameglio F., Lulli P., Matassa P.G., Carrozza C., Santini S.A., Antenucci M., Castagnola M., Giardina B., Romagnoli C., Zuppi C. Increased levels of IGF-1 and beta2-microglobulin in epithelial lining fluid of preterm newborns developing chronic lung disease, effects of rhG-CSF. Int. J. Immunopathol. Pharmacol. 19(1):57-66, 2006.
6. Oppenheim JJ. Ruscetti F.W.. Cytokines. In Medical Immunology, 9th ed. O.P. Stiles, A.I. Terr and T.G. Parslow. Appleton and Lange Stamford, Connecticut, p.146, 1997.
7. Mayer I.A. Targeting cytokine receptors and pathways in the treatment of breast cancer. Cancer Treat. Res. 126:243-62, 2005.
8. Totaro R., Passacantando A., Russo T., Parzanese I., Rascente M., Marini C., Tonietti G., Carolei A. Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis. Int. J. Immunopathol. Pharmacol. 18(2):377-83, 2005.
9. Marinova S., Nenkov P., Markova R., Nikolaeva S., Kostadinova R., Mitov I., Vretenarska M. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int. J. Immunopathol. Pharmacol. 18(3):457-473, 2005.
10. Liu Q., Hamblin M.R. Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state. Int. J. Immunopathol. Pharmacol. 18(3):391-402, 2005.
11. Castellani M.L., Salini V., Frydas S., Donelan J., Madhappan B., Petrarca C., Vecchiet J., Falasca K., Neri G., Tete S. Interleukin-31: a new cytokine involved in inflammation of the skin. Int. J. Immunopathol. Pharmacol. 19(1): 1-4, 2006.
12. Marcucci F., Sensi L., Di Cara G., Gidaro G., Incorvaia C., Frati F. Sublingual reactivity to rBET V1 and rPHL P1 in patients with oral allergy syndrome. Int. J. Immunopathol. Pharmacol. 19(1):141-8, 2006.
13. Di Giannantonio M., Frydas S., Kempuraj D., Karagouni E., Hatzistilianou M., Conti C.M., Boucher W., Papadopoulou N., Donelan J., Cao J., Madhappan B., Boscolo P., Petrarca C., Castellani L., Quartesan L., Doyle R., Ferro F.M. Cytokines in stress. Int. J. Immunopathol. Pharmacol. 18(1):1-5, 2005.
14. Galdiero M., Pisciotta M.G., Gorga F., Petrillo G., Marinelli A., Galdiero E. Modulation of costimulatory molecules CD80/CD86 on B cells and macrophages by stress proteins GroEL, GroES and DnaK. Int. J. Immunopathol. Pharmacol. 18(4):637-44, 2005.
15. Torres M.J., Mayorga C., Fernandez T.D., Cornejo-Garcia J.A., Antunez C., Valenzuela M., Del Prado M.F., Rodriguez-Pena R., Bianca M. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int. J. Immunopathol. Pharmacol. 19(1):119-30, 2006.
16. Giri J.G., Anderson D.M., Kumaki S., Park L.S., Grabstein K.H., Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukoc. Biol. 57(5):763-6), 1995.
17. Fehniger T.A., Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood. 97(1):14-32, 2001.
18. Anderson D. M., Kumaki S., Ahdieh M., Bertles J., Tometsko M., Loomis A., Giri J., Copeland N. G., Gilbert D. J., Jenkins N. A., Valentine V., Shapiro D. N., Morris S. W., Park L. S., Cosman E. Functional characterization of the human interleukin-15 receptor chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270: 29862-29869, 1995.
19. Lee J.M, Chung C.Y., Chiang W.W., Liou Y.H., Chen C.F., Liao N.S. IL-15Ralpha is a negative regulator of TCR-activated proliferation in CD4+ T cells. J. Immunol. 173(5):3155-64, 2004.
20. Bamford R.N., Grant A.J., Burton J.D., Peters C., Kurys G., Goldman C.K., Brennan J., Roessler E., Waldmann T.A. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA. 91(11):4940-4, 1994.
21. Benczik M., Gaffen S.L. The interleukin (IL)-2 family cytokines: survival and proliferation signalling pathways in T lymphocytes. Immunol. Invest. 33(2): 109-42, 2004.
22. Conti P., Toniato E., Robuffo I., Vecchiet J., Iezzi T., Madhappan B., Kempuraj D. Interleukin 27 (IL-27): A novel pleiotropic cytokine involved in T cell differentiation and T cell response modulation. Int. J. Immunopathol. Pharmacol. 18(2): 191-4, 2005.
23. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., Bougras G., Muller W.A., Moretta L., Munz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA. 101(47):16606-11, 2004.
24. Marks-Konczalik J., Dubois S., Losi J.M., Sabzevari H., Yamada N., Feigenbaum L., Waldmann T.A., Tagaya Y. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc. Natl. Acad. Sci. USA. 97(21): 11445-50, 2000.
25. Kennedy M.K., Glaccum M, Brown S.N., Butz E.A., Viney J.L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C.R., Brasel K., Morrissey P.J., Stocking K., Schuh J.C., Joyce S., Peschon J.J. Reversible defects in natural killer and memory CDS T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191(5):771-80, 2000.
26. Porter B.O., Malek T.R. IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of gammac-/- mice: roles for both IL-2 and IL-15 in CDSalphaalpha IEL development. J. Immunol. 163(11):5906-12, 1999.
27. Bassiri H., Carding S.R. A requirement for IL-2/IL-2 receptor signaling in intrathymic negative selection. J. Immunol. 166(10):5945-54, 2001.
28. Giron-Michel J., Caignard A., Fogli M., Brouty-Boye D., Briard D., van Dijk M., Meazza R., Ferrini S., Lebousse-Kerdiles C., Clay D., Bompais H., Chouaib S., Peault B., Azzarone B. Differential STATS, STATS, and NF-kappaB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules. Blood. 102(1):109-17, 2003.
29. Sotiriadou N.N., Perez S.A., Gritzapis A.D., Mahaira L.G., Salagianni M., Baxevanis C.N., Papamichail M. Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function. Cell. Immunol. 234(1):67-75, 2005.
30. Musso T., Calosso L., Zucca M., Millesimo M., Puliti M., Bulfone-Paus S., Merlino C., Savoia D., Cavallo R., Ponzi A.N., Badolato R. Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells. Infect. Immun. 66(6):2640-7, 1998.
31. Penta M., Fioriti D., Chinazzi A., Pietropaolo V., Conte M.P., Schippa S., Tecca M., Gentile V., De Dominicis C., Chiarini F. Encrusted cystitis in an immunocompromised patient: possible coinfection by Corynebacterium urealyticum and E. coli. Int. J. Immunopathol. Pharmacol. 19(1):241-4, 2006.
32. Varricchio A., Tricarico D., De Lucia A., Utili R., Tripodi M.F., Miraglia Del Giudice M., Capasso M., Sabatino G., Sgarrella M., Marseglia G.L., Ciprandi G. Inhaled tobramycin in children with acute bacterial rhinopharyngitis. Int. J. Immunopathol. Pharmacol. 19(1): 131-40, 2006.
33. Cassano N., Loconsole F., Galluccio A., Miracapillo A., Pezza M., Vena G.A. Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study). Int. J. Immunopathol. Pharmacol. 19(1):225-229, 2006.
34. Alleva D.G., Kaser S.B., Monroy M.A., Fenton M.J., Beller D.I. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J. Immunol. 159(6):2941-51, 1997.
35. Masuda A., Matsuguchi T., Yamaki K., Hayakawa T., Kubo M., LaRochelle W.J., Yoshikai Y. Interleukin-15 induces rapid tyrosine phosphorylation of STAT6 and the expression of interleukin-4 in mouse mast cells. J. Biol. Chem. 275(38):29331-7, 2000.
36. Galdiero M., Pisciotta M.G., Gorga F., Petrillo G., Marinelli A., Galdiero E. Modulation of costimulatory molecules CD80/CD86 on B cells and macrophages by stress proteins GroEL, GroES and DnaK. Int. J. Immunopathol. Pharmacol. 18(4):637-44, 2005.
37. Miranda-Carus M.E., Benito-Miguel M.., Llamas M.A., Balsa A., Martin-Mola E. Human T cells constitutively express IL-15 that promotes ex vivo T cell homeostatic proliferation through autocrine/juxtacrine loops. J. Immunol. 175(6):3656-62, 2005.
38. Burkett P.R., Koka R., Chien M., Chai S., Boone D.L., Ma A. Coordinate Expression and Trans Presentation of Interleukin (IL)-15R{alpha}and IL-15 Supports Natural Killer Cell and Memory CD8+ T Cell Homeostasis. J. Exp. Med. 200(7): 825-834, 2004.
39. Conti P., Kempuraj D., Di Gioacchino M., Boucher W., Letourneau R., Kandere K., Barbacane R.C., Reale M., Felaco M., Frydas S., Theoharides T.C. Interleukin-6 and mast cells. Allergy Asthma Proc. 23(5):331-5, 2002.
40. Conti P., Kempuraj D., Boucher W., Letourneau R., Theoharides T.C. Mechanism by which IL-16 generated by mast cells mediates allergic inflammation. Int. J. Immunopathol. Pharmacol. 14(1): 1-4, 2001.
41. Theoharides T.C., Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 25(5):235-41, 2004.
42. Lucas HJ., Brauch C.M., Settas L., Theoharides T.C. Fi bromyalgia - new concepts of pathogenesis and treatment. Int. J. Immunopathol. Pharmacol. 19(1):5-10, 2006.
43. Cassano N., Loconsole F., Coviello C., Vena G.A. Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int. J. Immunopathol. Pharmacol. 19(1):237-40, 2006.
44. Logothetis L., Mylonas I.A., Baloyannis S., Pashalidou M., Orologas A., Zafeiropoulos A., Kosta V., Theoharides T.C. A pilot, open label, clinical trial using hydroxyzine in Multiple Sclerosis. Int. J. Immunopathol. Pharmacol. 18(4):771-8, 2005.
45. Avgerinos D.V, Theoharides T.C. Mesenteric traction syndrome or gut in distress. Int. J. Immunopathol. Pharmacol. 18(2): 195-9, 2005.
46. Kalogeromitros D., Kempuraj D., Katsarou-Katsari A., Gregoriou S., Makris M., Boucher W., Theoharides T.C. Theophylline as "add-on" therapy in patients with delayed pressure urticaria: a prospective self-controlled study. Int. J. Immunopathol. Pharmacol. 18(3):595-602, 2005.
47. Bulanova E., Budagian V., Orinska Z., Krause H., Paus R., Bulfone-Paus S. Mast cells express novel functional IL-15 receptor alpha isoforms. J. Immunol. 170(10):5045-55, 2003.
48. Masuda A., Matsuguchi T., Yamaki K., Hayakawa T., Yoshikai Y. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J. Biol. Chem. 276(28):26107-13, 2001.
49. Artese L., Ucchino S., Piattelli A., Piccirilli M., Perrotti V., Mezzetti A., Cipollone F. Factors associated with apoptosis in symptomatic and asymptomatic carotid atherosclerotic plaques. Int. J. Immunopathol. Pharmacol. 18(4):645-53, 2005.
50. Gonzalez M.I., Rubinstein N., Ilarregui J.M., Toscano M.A., Sanjuan N.A., Rabinovich G.A. Regulated expression of Galectin-1 after in vitro productive infection with herpes simplex virus type 1: implications for T cell apoptosis. Int. J. Immunopathol. Pharmacol. 18(4):615-23, 2005.
51. Jackson N.E, Wang H.W., Tedla N., McNeil H.P., Geczy C.L., Collins A., Grimm M.C., Hampartzoumian T., Hunt J.E. IL-15 induces mast cell migration via a pertussis toxin-sensitive receptor. Eur. J. Immunol. 35(8):2376-85, 2005.
52. Woolley D.E., Tetlow L.C. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res. 2(1):65-74, 2000.
53. Yamaki K., Uchida H., Ei X., Yanagisawa R., Takano H., Hayashi H., Mori Y., Yoshino S. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 18(1):133-44, 2005.
54. Alleva, D.G., Kaser S.B., Monroy M.A., Fenton M.J., Beller D.I.. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J. Immunol. 159:2941, 1997.
55. Perrella A., Borgia G., Borrelli R, Di Sirio S., Gnarini M., Grattacaso S., Graf M., Guida M., Viola C., Guarnaccia M., Perrella O. TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitus. Int. J. Immunopathol. Pharmacol. 18(1): 189-93, 2005.
56. Gorbunov N.V., McFaul S.J., Januszkiewicz A., Atkins J.E. Pro-inflammatory alterations and status of blood plasma iron in a model of blast-induced lung trauma. Int. J. Immunopathol. Pharmacol. 18(3):547-56, 2005.
57. Ausiello C.M., Palazzo R., Spensieri F., Urbani F., Massari M., Triebel F., Benagiano M., D'Elios M.M., Del Prete G., Cassone A. Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine. Int. J. Immunopathol. Pharmacol. 19(1):97-104, 2006.
58. Becknell B., Caligiuri M.A. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv. Immunol. 86:209-39, 2005.
59. Esposito I., Perna F., Ponticiello A., Perrella M., Gilli M., Sanduzzi A. Natural killer cells in Ba1 and peripheral blood of patients with idiopathic pulmonary fibrosis (IPF). Int. J. Immunopathol. Pharmacol. 18(3):541-5, 2005.
60. Weng N.P., Liu K., Catalfamo M., Li Y., Henkart P.A. IL-15 is a growth factor and an activator of CD8 memory T cells. Ann. N Y Acad. Sci. 975:46-56, 2002.
61. Berard M., Brandt K., Bulfone-Paus S., Tough D.F. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J. Immunol. 170(10):5018-26, 2003.
62. Somma P., Lo Muzio L., Mansueto G., Delfino M., Fabbrocini G., Mascolo M., Mignogna C., Di Benedetto M., Carinci F., De Lillo A., Pastore L., Serpico R., De Rosa G., Staibano S. Squamous cell carcinoma of the lower lip: FAS/FASL expression, lymphocyte subtypes and outcome. Int. J. Immunopathol. Pharmacol. 18(1):59-64, 2005.
63. Azzurri A., Kanaujia G.V., Sow O.Y., Bah B., Diallo A., Del Prete G., Gennaro M.L. Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea. Int. J. Immunopathol. Pharmacol. 19(1):199-208, 2006.
64. Zhao H., Nguyen H., Kang J. Interleukin 15 controls the generation of the restricted T cell receptor repertoire of gamma delta intestinal intraepithelial lymphocytes. Nat. Immunol. 6(12):1263-71, 2005.
65. d'Ettorre G., Forcina G., Andreotti M., Sarmati L., Palmisano L., Andreoni M., Vella S., Mastroianni C.M., Vullo V. Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV infected patients with discordant response to highly active antiretroviral therapy. Clin. Exp. Immunol. 135(2):280-5, 2004.
66. De Luca M., Miccinesi G., Chiappini E., Zappa M., Galli L., De Martino M. Different kinetics of immunologic recovery using nelfinavir or lopinavir/ritonavir-based regimens in children with perinatal HIV-1 infection. Int. J. Immunopathol. Pharmacol. 18(4):729-35, 2005.
67. Pastore L., Fiore J.R., Tateo M., De Benedittis M., Petruzzi M., Casalino C., Genchi C., Lo Muzio L., Angarano G., Serpico R. Detection of hepatitis C virus-RNA in saliva from chronically HCV-infected patients. Int. J. Immunopathol. Pharmacol. 19(1):217-24, 2006.
68. Azimi N., Mariner J., Jacobson S., Waldmann T.A. How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy/tropical spastic paraparesis? AIDS Res. Hum. Retroviruses. 16(16):1717-22, 2000.
69. Falkensammer B., Fasser W., Scherer K., Zemann A., Parson W., Ulmer H., Dierich M.P., Stoiber H. Drug monitoring and viral response to lopinavir/ritonavir or saquinavir/ritonavir containing regimens in individuals infected with the human immunodeficiency virus type 1. Int. J. Immunopathol. Pharmacol. 18(1): 145-54, 2005.
70. Martini F., Agrati C., D'Offizi G., Poccia F. HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells. Int. J. Immunopathol. Pharmacol. 18(2):269-76, 2005.
71. Nishiwaki T., Ina K., Goto H., Watanabe O., Tsuzuki T., Furuta R., Ando T., Hibi K., Kusugami K. Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease. J. Gastroenterol. 40(2): 128-36, 2005.
72. Guidi L., Costanzo M., Ciarniello M., De Vitis I., Pioli C., Gatta L., Pace L., Tricerri A., Bartoloni C., Coppola L., Balistreri P., Doria G., Fedeli G., Gasbarrini G.B. Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment. Int. J. Immunopathol. Pharmacol. 18(1):155-64, 2005.
73. Kukita T., Arima N., Matsushita K., Arimura K., Ohtsubo H., Sakaki Y., Fujiwara H., Ozaki A., Matsumoto T., Tei C. Autocrine and/or paracrine growth of adult T-cell leukaemia tumour cells by interleukin 15. Br. J. Haematol. 119(2):467-74, 2002.
74. Trentin L., Cerutti A., Zambello R., Sancretta R., Tassinari C., Facco M., Adami F., Rodeghiero F., Agostini C., Semenzato G. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood. 87(8):3327-35, 1996.
75. Greco C., D'Agnano I., Vitelli G., Vona R., Marino M., Mottolese M., Zuppi C., Capoluongo E., Ameglio F. c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB. Int. J. Immunopathol. Pharmacol. 19(1):67-79, 2006.
76. Marino F., Guasti L., Cosentino M., De Piazza D., Simoni C., Bianchi V., Piantanida E., Saporiti F., Cimpanelli M.G., Crespi C., Vanoli P., De Palma D., Klersy C., Frigo G.M., Bartalena L., Venco A., Lecchini S. Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies. Int. J. Immunopathol. Pharmacol. 19(1):149-60, 2006.
77. Dubois S.P., Waldmann T.A., Muller J.R. Survival adjustment of mature dendritic cells by IL-15. Proc. Natl. Acad. Sci. USA. 102(24):8662-7, 2005.
78. Lazarova P., Wu Q., Kvalheim G., Suo Z., Haakenstad K.W., Metodiev K., Nesland J.M. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood. Int. J. Immunopathol. Pharmacol. 19(1):49-56, 2006.
79. Ohteki T., Suzue K., Maki C., Ota T., Koyasu S. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol. 2(12):1138-43, 2001.
80. Tourkova I.L., Yurkovetsky Z.R., Gambotto A., Makarenkova V.P., Ferez L., Balkir L., Robbins P.D., Shurin M.R., Shurin G.V. Increased function and survival of IL-15-transduced human dendritic cells are mediated by up-regulation of IL-15Ralpha and Bcl-2. J Leukoc Biol. 72(5):1037-45, 2002.
81. Granucci F., Zanoni I., Pavelka N., Van Dommelen S.L., Andoniou C.E., Belardelli F., Degli Esposti M.A., Ricciardi-Castagnoli P. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 200(3):287-95, 2004.
82. Feau S., Facchinetti V., Granucci F., Citterio S., Jarrossay D., Seresini S., Protti M.P., Lanzavecchia A., Ricciardi-Castagnoli P. Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. Blood. 105(2):697-702, 2005.
83. Koka R., Burkett P., Chien M., Chai S., Boone D.L., Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J. Immunol. 173(6):3594-8, 2004.
84. Ruckert R., Brandt K., Bulanova E., Mirghomizadeh F., Paus R., Bulfone-Paus S. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur. J. Immunol. 33(12):3493-503, 2003.
85. Ausiello C.M., Palazzo R., Spensieri F., Urbani F., Massari M., Triebel F.,Benagiano M., D'Elios M.M., Del Prete G., Cassone A. Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine. Int. J. Immunopathol. Pharmacol. 19(1):97-104, 2006.
86. Barata J.T., Keenan T.D., Suva A., Nadler L.M., Boussiotis V.A., Cardoso A.A. Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia. Haematologica. 89(12):1459-67, 2004.
87. Morris J.C., Janik J.E., White J.D., Fleisher T.A., Brown M., Tsudo M., Goldman C.K., Bryant B., Petrus M., Top L., Lee C.C., Gao W., Waldmann T.A. Preclinical and phase I clinical trial of blockade of IL-15 using Mik{beta}l monoclonal antibody in T cell large granular lymphocyte leukemia. Proc. Natl. Acad. Sci. USA. 103(2):401-6, 2006.
88. Di Lorenzo G., De Placido S. Hormone refractory prostate cancer (HRPC): present and future approaches of therapy. Int. J. Immunopathol. Pharmacol. 19(1):11-34, 2006.
89. Gentile V., Vicini P., Giacomelli L., Cardillo M.R., Pierangeli A., Degener A.M. Detection of human papillomavirus DNA, p53 and ki67 expression in penile carcinomas. Int. J. Immunopathol. Pharmacol. 19(1):209-215, 2006.
90. Franconi R., Massa S., Illiano E., Mullar A., Cirilli A., Accardi L., Di Bonito P., Giorgi C., Venuti A. Exploiting the plant secretory pathway to improve the anticancer activity of a plant-derived HPV16 E7 vaccine. Int. J. Immunopathol. Pharmacol. 19(1):187-97, 2006.
91. Demirci G., Li X.C. IL-2 and IL-15 exhibit opposing effects on Fas mediated apoptosis. Cell. Mol. Immunol. 1(2): 123-8, 2004.
92. Ruckert R., Asadullah K., Seifert M., Budagian V.M, Arnold R., Trombotto C., Paus R., Bulfone-Paus S. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J. Immunol. 165(4):2240-50, 2000.
93. Caproni M., Torchia D., Antiga E., Degl'innocenti D., Barletta E., Baroni G., Santucci M., Fabbri P. The role of apoptosis in the pathogenesis of dermatitis herpetiformis. Int. J. Immunopathol. Pharmacol. 18(4):691-9, 2005.
94. Cavalieri S., Rotoli M., Feliciani C., Amerio P. Expression of the high-affinity laminin receptor (67 kDa) in normal human skin and appendages. Int. J. Immunopathol. Pharmacol. 18(2):223-31, 2005.
95. He Y.G., Mayhew E., Mellon J., Niederkorn J.Y. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells. Invest. Ophthalmol Vis. Sci. 45(12):4240-6, 2004.
96. Belli R., Amerio P., Brunetti L., Orlando G., Toto P., Proietto G., Vacca M., Tulli A. Elevated 8-isoprostane levels in basal cell carcinoma and in UVA irradiated skin. Int. J. Immunopathol. Pharmacol. 18(3):497-502, 2005.
97. Cantaluppi V., Deregibus M.C., Biancone L., Deambrosis I., Bussolati B., Albini A., Camussi G. The expression of CD154 by Kaposis sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein. Int. J. Immunopathol. Pharmacol. 19(1):81-96, 2006.
98. Deambrosis I., Scalabrino E., Deregibus M.C., Camussi G., Bussolati B. CD40-dependent activation of phosphatidylinositol 3-kinase/AKT pathway inhibits apoptosis of human cultured mesangial cells induced by oxidized LDL. Int. J. Immunopathol. Pharmacol. 18(2):327-37, 2005.
99. Licastro F., Chiappelli M., Porcellini E., Trabucchi M., Marocchi A., Corsi M.M. Altered vessel signalling molecules in subjects with Downs syndrome. Int. J. Immunopathol. Pharmacol. 19(1):181-5, 2006.
100. Waldmann T.A. The IL-2/IL-15 receptor systems: targets for immunotherapy. J. Clin. Immunol. 22(2):51-6, 2002.
101. Lo Iacono M., Cavallo R, Quaglino E., Rolla S., Iezzi M., Pupa S.M., De Giovanni C., Lollini P.L., Musiani P., Forni G., Calogero R.A. A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. Int. J. Immunopathol. Pharmacol. 18(2):351-63, 2005.
102. Lin S.J., Cheng P.J., Hsiao S.S., Lin H.H., Hung P.P., Kuo M.L. Differential effect of IL-15 and IL-2 on survival of phytohemagglutinin- activated umbilical cord blood T cells. Am. J. Hematol. 80(2): 106-12, 2005.
103. Klebanoff C.A., Finkelstein S.E., Surman D.R., Lichtman M.K., Gattinoni L., Theoret M.R., Grewal N., Spiess P.J., Antony P.A., Palmer D.C., Tagaya Y., Rosenberg S.A., Waldmann T.A., Restifo N.P. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc. Natl. Acad. Sci. USA. 101(7):1969-74, 2004.
104. Konishi T., Watanabe T., Shibahara J., Nagawa H. Surveillance colonoscopy should be conducted in patients with colorectal Shistosomiasis even after successful treatment of the disease. Int. J. Immunopathol. Pharmacol. 19(1):245-6, 2006.
105. Ozdemir O., Ravindranath Y., Savasan S. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells. J. Immunother. 28(1):44-52, 2005.
106. Mingari M.C., Ponte M., Bertone S., Schiavetti F., Vitale C., Bellomo R., Moretta A., Moretta L. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc. Natl. Acad. Sci. U S A. 95(3):1172-7, 1998.
107. Staibano S., Mascolo M., Tranfa R, Salvatore G., Mignogna C., Bufo P., Nugnes L., Bonavolont X00e0 G, De Rosa G. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior? Int. J. Immunopathol. Pharmacol. 19(1):171-179, 2006.
108. Wu S., Gessner R., von Stackelberg A., Kirchner R., Henze G., Seeger K. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence. Cancer. 103(5):1054-63, 2005.
109. Spaner D.E., Hammond C., Mena J., Shi Y. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy. Br. J. Haematol. 127(5):531-42, 2004.
110. Bongrazio M., Da Silva-Azevedo L., Bergmann B.C., Baum O., Hinz B., Pries A.R., Zakrzewicz A. Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo. Int. J. Immunopathol. Pharmacol. 19(1):35-48, 2006.
111. Brentjens R.J., Latouche J.B., Santos E., Marti R, Gong M.C., Lyddane C., King P.D., Larson S., Weiss M., Riviere I., Sadelain M. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat. Med. 9(3):279-86, 2003.
112. Anichini A., Mortarini R., Romagnoli L., Baldassari P., Cabras A., Carlo-Stella C., Gianni A.M., Di Nicola M. Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with {gamma}c cytokines. Blood. 107(2):602-9, 2006.
113. league R.M., Sather B.D., Sacks J.A., Huang M.Z., Dossett M.L., Morimoto J., Tan X., Sutton S.E., Cooke M.P., Ohlen C., Greenberg P.D. Interleukin-15 rescues tolerant CD8(+) T cells for use in adoptive immunotherapy of established tumors. Nat Med. 12(3):335-41, 2006.
114. Kuniyasu H., Ohmori H., Sasaki T., Sasahira T., Yoshida K., Kitadai Y., Fidler I.J. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. Clin. Cancer Res. 9(13):4802-10, 2003.
115. Castellani M.L., Salini V., Frydas S., Donelan J,. Tagen M., Madhappan B., Petrarca C., Falasca K., Neri G., Tete S., Vecchiet J.: The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity. Int. J. Immunopathol. Pharmacol.; 19(2):247-252, 2006.
116. Di Lorenzo G., De Placido S.: Hormone refractory prostate cancer (HRPC):present and future approaches of therapy. Int. J. Immunopathol. Pharmacol.; 19:11-34, 2006.
117. Castellani M.L., Salini V., Frydas S., Donelan J., Madhappan B., Petrarca C., Vecchiet J., Falasca K., Neri G., Tete S.: Interleukin-31: a new cytokine involved in inflammation of the skin. Int. J. Immunopathol. Pharmacol; 19:1-4, 2006.